Physician profile
Craig Couch
NPI 1568497733
$15,259.64
in general payments reported to CMS, 2019-2025
59 companies · $2,853 in 2025
The $2,853 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,850 · 2020: $1,540 · 2021: $2,299 · 2022: $1,886 · 2023: $2,306 · 2024: $2,525 · 2025: $2,853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,533 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,533.43 |
| Education | $150.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $1,212.92 | 2021-2025 | Ocrevus Zunovo, Ocrevus |
| Teva Pharmaceuticals USA, INC. | $1,121.41 | 2019-2025 | Ajovy, Austedo, Austedo Xr |
| Abbvie INC. | $1,095.27 | 2021-2025 | Ubrelvy, Qulipta |
| Novartis Pharmaceuticals Corporation | $1,033.42 | 2019-2025 | |
| Ucb, INC. | $980.53 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
| Lilly USA, LLC | $775.33 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Amgen INC. | $769.69 | 2019-2023 | Aimovig |
| Lundbeck LLC | $712.93 | 2019-2025 | Vyepti |
| Pfizer INC. | $623.90 | 2019-2025 | |
| Biogen, INC. | $533.29 | 2019-2025 | Tysabri, Vumerity, Leqembi |
| Jazz Pharmaceuticals INC. | $525.83 | 2019-2025 | |
| Genzyme Corporation | $477.08 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $409.94 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $377.28 | 2019-2025 | Ultomiris |
| Sk Life Science, INC. | $371.47 | 2020-2025 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Couch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.